Viridian Therapeutics, Inc. VRDN EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s EV / sales?
- Viridian Therapeutics, Inc. (VRDN) reported EV / sales of 26.2× in Q1 2026.
- How has Viridian Therapeutics, Inc.'s EV / sales changed year-over-year?
- Viridian Therapeutics, Inc.'s EV / sales decreased by 99.2% year-over-year, from 3,328.8× to 26.2×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s EV / sales?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s EV / sales has grown at a -6.7% compound annual growth rate (CAGR), from 55.7× to 39.4×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.